Contribute Try STAT+ Today

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our modest agenda includes catching up on our reading, promenading with the official mascot, and finding fun food for our hard-working short person. And what about you? This may be a good time to get vaccinated, assuming supplies are available. You could get a jump on spring cleaning. Or bolster the economy by arranging for restaurant takeout. Well, whatever you do, have a grand time. But be safe — wear a mask. Enjoy, and see you soon. …

The head of the Serum Institute of India, the world’s biggest vaccine maker, said manufacturers of Covid-19 shots face a global shortage of the raw materials needed to churn out the inoculations, Bloomberg News reports. Adar Poonawalla told a World Bank panel that a U.S. law blocking the export of certain key items, including bags and filters, will likely cause serious bottlenecks. Soumya Swaminathan from the World Health Organization added that there were shortfalls of vials, glass, plastic, and stoppers required by those companies.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Thanks for the reminder mr ed – now I will raise an other old question. Given that he is gone after – “His companies raised the price for Daraprim by more than 4,000% ” …did said company EVER lower their price$ for this? “Inquiring minds … “

Comments are closed.